Integra LifeSciences Holdings Net Profit Margin 2010-2024 | IART
Integra LifeSciences Holdings net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Integra LifeSciences Holdings Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-12-31 | $1.61B | $-0.01B | -0.43% |
| 2024-09-30 | $1.57B | $-0.01B | -0.38% |
| 2024-06-30 | $1.57B | $0.02B | 1.53% |
| 2024-03-31 | $1.53B | $0.04B | 2.62% |
| 2023-12-31 | $1.54B | $0.07B | 4.35% |
| 2023-09-30 | $1.54B | $0.10B | 6.49% |
| 2023-06-30 | $1.55B | $0.13B | 8.48% |
| 2023-03-31 | $1.56B | $0.17B | 11.01% |
| 2022-12-31 | $1.56B | $0.18B | 11.62% |
| 2022-09-30 | $1.57B | $0.17B | 11.05% |
| 2022-06-30 | $1.57B | $0.17B | 10.59% |
| 2022-03-31 | $1.56B | $0.16B | 10.00% |
| 2021-12-31 | $1.54B | $0.17B | 10.89% |
| 2021-09-30 | $1.53B | $0.22B | 14.15% |
| 2021-06-30 | $1.51B | $0.21B | 13.59% |
| 2021-03-31 | $1.38B | $0.17B | 12.34% |
| 2020-12-31 | $1.37B | $0.13B | 9.77% |
| 2020-09-30 | $1.38B | $0.06B | 4.06% |
| 2020-06-30 | $1.39B | $-0.00B | -0.29% |
| 2020-03-31 | $1.51B | $0.03B | 1.72% |
| 2019-12-31 | $1.52B | $0.05B | 3.29% |
| 2019-09-30 | $1.51B | $0.06B | 3.98% |
| 2019-06-30 | $1.49B | $0.10B | 6.76% |
| 2019-03-31 | $1.48B | $0.08B | 5.56% |
| 2018-12-31 | $1.47B | $0.06B | 4.08% |
| 2018-09-30 | $1.46B | $0.08B | 5.42% |
| 2018-06-30 | $1.37B | $0.07B | 5.03% |
| 2018-03-31 | $1.29B | $0.07B | 5.36% |
| 2017-12-31 | $1.19B | $0.06B | 5.38% |
| 2017-09-30 | $1.08B | $0.05B | 4.46% |
| 2017-06-30 | $1.05B | $0.07B | 6.21% |
| 2017-03-31 | $1.01B | $0.07B | 6.61% |
| 2016-12-31 | $0.99B | $0.07B | 7.46% |
| 2016-09-30 | $0.98B | $0.06B | 6.24% |
| 2016-06-30 | $0.95B | $0.01B | 0.94% |
| 2016-03-31 | $0.92B | $0.00B | 0.11% |
| 2015-12-31 | $0.88B | $-0.00B | -0.45% |
| 2015-09-30 | $0.80B | $-0.00B | -0.25% |
| 2015-06-30 | $0.77B | $0.04B | 5.22% |
| 2015-03-31 | $0.79B | $0.04B | 5.10% |
| 2014-12-31 | $0.80B | $0.03B | 4.27% |
| 2014-09-30 | $0.73B | $0.03B | 4.28% |
| 2014-06-30 | $0.74B | $-0.01B | -1.22% |
| 2014-03-31 | $0.72B | $-0.01B | -1.68% |
| 2013-12-31 | $0.70B | $-0.02B | -2.87% |
| 2013-09-30 | $0.83B | $-0.02B | -2.53% |
| 2013-06-30 | $0.83B | $0.02B | 2.66% |
| 2013-03-31 | $0.83B | $0.03B | 3.49% |
| 2012-12-31 | $0.83B | $0.04B | 5.06% |
| 2012-09-30 | $0.82B | $0.03B | 4.15% |
| 2012-06-30 | $0.81B | $0.03B | 3.94% |
| 2012-03-31 | $0.80B | $0.02B | 3.02% |
| 2011-12-31 | $0.78B | $0.03B | 3.59% |
| 2011-09-30 | $0.77B | $0.04B | 5.45% |
| 2011-06-30 | $0.76B | $0.05B | 6.23% |
| 2011-03-31 | $0.74B | $0.06B | 8.23% |
| 2010-12-31 | $0.73B | $0.07B | 8.87% |
| 2010-09-30 | $0.72B | $0.06B | 8.58% |
| 2010-06-30 | $0.71B | $0.06B | 8.47% |
| 2010-03-31 | $0.70B | $0.06B | 8.06% |
| 2009-12-31 | $0.68B | $0.05B | 7.47% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.698B | $1.611B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $187.725B | 22.76 |
| Intuitive Surgical (ISRG) | United States | $176.405B | 80.93 |
| Alcon (ALC) | Switzerland | $46.824B | 31.12 |
| Edwards Lifesciences (EW) | United States | $42.608B | 27.66 |
| IDEXX Laboratories (IDXX) | United States | $34.032B | 39.36 |
| IQVIA Holdings (IQV) | United States | $31.084B | 17.20 |
| DexCom (DXCM) | United States | $26.777B | 41.39 |
| Mettler-Toledo (MTD) | United States | $24.611B | 28.69 |
| STERIS (STE) | Ireland | $22.269B | 25.47 |
| Waters (WAT) | United States | $21.897B | 31.05 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.380B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.612B | 14.91 |
| Hologic (HOLX) | United States | $13.861B | 14.96 |
| Sysmex ADR (SSMXY) | Japan | $11.941B | 37.44 |
| Penumbra (PEN) | United States | $10.300B | 93.17 |
| Globus Medical (GMED) | United States | $10.068B | 23.31 |
| Masimo (MASI) | United States | $9.002B | 37.78 |
| Teleflex (TFX) | United States | $6.407B | 9.86 |
| Glaukos (GKOS) | United States | $5.567B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.967B | 22.27 |
| PROCEPT BioRobotics (PRCT) | United States | $3.194B | 0.00 |
| Veracyte (VCYT) | United States | $2.311B | 41.76 |
| TransMedics (TMDX) | United States | $2.265B | 66.61 |
| Nihon Kohden (NHNKY) | Japan | $2.205B | 12.06 |
| LivaNova (LIVN) | United Kingdom | $2.135B | 12.96 |
| Elekta AB (EKTAY) | Sweden | $1.995B | 17.93 |
| Alphatec Holdings (ATEC) | United States | $1.462B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.274B | 0.00 |
| OPKO Health (OPK) | United States | $1.115B | 0.00 |
| Paragon 28 (FNA) | United States | $1.096B | 0.00 |
| Artivion (AORT) | United States | $1.034B | 98.32 |
| RxSight (RXST) | United States | $1.022B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| AxoGen (AXGN) | United States | $0.820B | 0.00 |
| IRadimed (IRMD) | United States | $0.667B | 34.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 10.61 |
| Mesa Laboratories (MLAB) | United States | $0.645B | 14.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.636B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.598B | 0.00 |
| SiBone (SIBN) | United States | $0.596B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.531B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.525B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.425B | 0.00 |
| NeuroPace (NPCE) | United States | $0.400B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.380B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.351B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.37 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| CVRx (CVRX) | United States | $0.318B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.313B | 16.73 |
| Nevro (NVRO) | United States | $0.224B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Accuray (ARAY) | United States | $0.184B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.177B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| 908 Devices (MASS) | United States | $0.158B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.123B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.117B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.114B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 11.82 |
| EDAP TMS S.A (EDAP) | France | $0.073B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.052B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.027B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |